copanlisib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (1)
Any (2)

Phase 1 (2)
Phase 1/2 (1)

Interventional (3)

Big Ten Cancer Research Consortium (1)
Brown University (1)
Duke University (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadgilbert's syndrome

I am/have/hadlipase

I am/have/hadneutrophil count

I am/have/hadlymphoma

I am/have/hadhair thinning

I am/have/hadmetastasis

I am/have/hadejection fraction

I am/have/hadhypothyroidism

I am/have/hadreplacement therapy

I am/have/hadalcoholic cirrhosis

I am/have/hadangina

I am/have/hadhormone replacement

I am/have/hadpneumonia

I am/have/hadhepatitis c

I am/have/hadliver metastases

I am/have/hadprimary tumor

I am/have/hadmetastatic castration-resistant prostate cancer

I am/have/hadhashimoto syndrome

added new label for I am/have/had

I am looking for

I am looking forcopanlisib

I am looking forlipase

I am looking forpi3k inhibitor

I am looking forcorticosteroids

I am looking forrituximab

I am looking forhba1c

I am looking forlhrh

I am looking forhormone therapy

I am looking fornivolumab

I am looking forprednisone

I am looking forendocrine therapy

I am looking forimmunosuppressive agents

I am looking forapalutamide

I am looking forcyp3a4 inhibitors

I am looking fortaxane

I am looking forcyp3a4 inducers

I am looking forppp2r2a

I am looking forrad51c

I am looking forabiraterone

I am looking forgnrh

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Recruiting

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

This is a single arm Phase Ib/II, open label, safety, pharmacokinetic and efficacy clinical study in adult patients with metastatic castration-resistant prostate cancer (mCRPC). Patients will be treated with the combination of copanlisib and rucaparib for as long as the patient does not have clinically significant progressive disease and/or unacceptable …

gonadotropin releasing hormone

carcinoma

metastatic castration-resistant prostate cancer

apalutamide

psa level

0 views
16 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

This protocol will test the hypotheses that REMD-477 is safe and tolerable in patients with severe hyperglycemia on copanlisib and that it decreases the risk of severe hyperglycemia in patients receiving copanlisib for relapsed refractory lymphoma

0 views
16 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive Copanlisib IV: day 1, 8, 15 every 28 days Nivolumab IV: Cycle 1 days 1 and 15; then day 1 only Rituximab IV: Cycle 1 days 1, 8, …

psoriasis

cyp3a4 inhibitors

interstitial lung disease

thyroiditis

unstable angina

0 views
16 Feb, 2024
1 location